\
&
Contact us
\
&
Contact us
Starts in 15 hours from now
LocationOnline
ProgrammesThis specialised online webinar will focus on how the future projects funded under the Cultural Heritage Cloud call topic of Horizon Europe’s Cluster 2 Work Programme 2025 will interact with the other Cloud projects and be integrated in the Cultural Heritage Cloud initiative.
This webinar is co-organised with the EU-funded project ECHOES, the project coordinating the Cultural Heritage Cloud initiative and developing the basic cloud platform, and the three sister Cloud projects selected under the 2023 call. During the webinar latest information about the Cultural Heritage Cloud implementation will be shared and there will be a possibility to ask live questions to the ECHOES consortium.
You can register here and already submit your questions in the registration form.
More information on this event can be found on this page.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI Continent Defence EDF NATO-EDA
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
